Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer.

Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer.

http://www.wikidata.org/entity/Q42437041

about

Pancreatic cancer: pathogenesis, prevention and treatment Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors.Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy The multiple facets of drug resistance: one history, different approaches.Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer.Targeted therapies for pancreatic cancer.Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells Current knowledge on pancreatic cancer.Apoptotic pathways in pancreatic ductal adenocarcinoma NF-kappaB signaling pathway and its therapeutic implications in human diseases.Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer.Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review.L1 cell adhesion molecule as a therapeutic target in cancer.18F-5-Fluoroaminosuberic Acid as a Potential Tracer to Gauge Oxidative Stress in Breast Cancer Models.A novel NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1.Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid.Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer.Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin.Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell lines.Nuclear factor κB is a key transcription factor in the duodenal contractility alterations induced by lipopolysaccharide.Solute carrier transporters: potential targets for digestive system neoplasms.

P2860

Q24670990-5B8BADB8-7793-4908-8265-E958488FA8EC Q28486199-00FEFA61-B1DF-4BE6-A99B-100E520230B6 Q33227187-D41DEEBF-FB6B-4A73-9F95-BA047928B981 Q33437264-D4DD5E79-E20C-450B-9B54-BF22519F9D91 Q33697116-489ABFD0-DBF0-4D5D-9E8E-A57B16B36BF5 Q33894596-460CA968-F208-4EF1-A682-6BE03EDF8704 Q33899923-14CEF693-2EAF-4905-B77D-7A95384B74FA Q34305783-998F4880-5A4E-477C-A683-FD48D1E4CDB3 Q34690409-359B5FE3-2392-4403-8E57-4E27D0883F5A Q35486194-C3D6C1FB-6FA7-46EC-A68A-E9F6483DABFC Q35971808-E49E5A2C-E8B3-4432-8FBE-7D80C63E8EC0 Q36835642-1DE58F35-77CD-441F-A203-DB8DB551A11B Q37293337-0E99499F-1CDB-4C36-A3E3-CD09EB1961F3 Q37348076-0689EDFD-E011-41D8-86C4-82211F6B83F6 Q37488862-999FDD00-D81C-4D6E-ABE1-71664BF9EE4D Q37853945-F3BE92CE-026C-4907-908F-A80A3642AD05 Q38701631-0D08176B-1095-4DB2-A07C-E56EADA2E501 Q38735688-4B1B4E1D-6F7A-4FAA-9340-A2CDACD1B393 Q38953653-61D5A562-A2D0-4494-B06A-867A8440A575 Q39020120-5ABE987F-1BB7-4891-BEDF-F2659864DCDE Q39344030-DBFAB510-AC77-4451-B234-373BD828FE1B Q39670791-1C83B087-1BE5-4009-A62C-7189E5657C52 Q40159774-357311C0-5ADD-403C-8D38-675BAA630A93 Q40419711-4222758F-C883-47E5-857B-07BE9B5B66C3 Q42727071-AAD9D99C-C966-4B59-A0E6-1AC1D64742D7 Q49667930-6C0A3DA4-E792-4695-8773-6A4849F9B05C

P2860

Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer.

http://www.wikidata.org/entity/Q42437041

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Usage of the NF-kappaB inhibit ...... otherapy of pancreatic cancer.

@en

Usage of the NF-kappaB inhibit ...... otherapy of pancreatic cancer.

@nl

type

label

Usage of the NF-kappaB inhibit ...... otherapy of pancreatic cancer.

@en

Usage of the NF-kappaB inhibit ...... otherapy of pancreatic cancer.

@nl

prefLabel

Usage of the NF-kappaB inhibit ...... otherapy of pancreatic cancer.

@en

Usage of the NF-kappaB inhibit ...... otherapy of pancreatic cancer.

@nl

P1433

Q42437041-EF8F4E27-7CCD-476F-9754-F7F99425C922

P1476

Q42437041-439980AF-EB23-4C0D-9665-4FFB7FF6C62F

P2093

Q42437041-015CF5A2-99FF-4544-89FC-8F8614F55517

Q42437041-07CEDBF0-1986-457B-8D22-F8B3616AFE7A

Q42437041-3D0C511C-5BAB-4CD2-ABB3-5F974BE35B7A

Q42437041-53E50749-F839-4CBA-95E3-DEFE19341DDF

Q42437041-71CCBCE8-5258-4D15-9491-9C383F53680E

Q42437041-870CC2B9-120A-4B3D-A44B-116DDC5DB87C

Q42437041-90974FB7-2261-48D1-A897-2F6A75FE0D49

Q42437041-9D91C7EA-0F52-42BA-8199-0D36C4BEDAD3

Q42437041-D2D60D0B-9B90-404C-B759-144F556CDF65

Q42437041-DC5B9192-2632-434E-8F5F-2130FE036793

P2860

Q42437041-0325ABBE-33AB-4FCC-9F10-B8E968373AFD

Q42437041-249E2DB1-5C61-4A2E-A926-29BB63AB8F0F

Q42437041-2F181777-24C1-4AA5-8648-CAB908C827DF

Q42437041-3403ED18-1C9E-4D11-BE23-B27611B76503

Q42437041-3F88A0FF-2DA2-4D99-8C42-0EB2E29134F4

Q42437041-634D8176-BFF2-4759-8EF4-CB61AA3F6661

Q42437041-6B7B9AB5-1668-4139-A6B9-0513215E6E27

Q42437041-6D6B970A-0FEB-4C58-83AB-1FB0511DB938

Q42437041-841343FD-E6A3-4CFC-94BF-7ACEF101F981

Q42437041-89DF4CCB-8C1A-44FD-99F7-3A45CD31C3C4

P304

Q42437041-D1BBA3C6-E6A1-4589-BDE8-BD558742544E

P31

Q42437041-F76E995E-A4FF-4D08-87CC-A293C23A7B7A

P356

Q42437041-D974C118-8C0C-4EEC-BEBE-FC6A71128DB3

P433

Q42437041-7DD8D217-1AE6-4B3A-86A2-AC84712D9A8E

P478

Q42437041-5A456E99-0209-46C9-A8CB-D948E69F46CA

P50

Q42437041-F7216CBA-B872-44EE-93AF-3A2526DF4438

P577

Q42437041-3160FECC-2E9E-49C2-93EF-A84966498DD6

P5875

Q42437041-4A12B093-8A2C-4BFC-B6BB-74C7D9A58B00

P698

Q42437041-60ECFF0A-1B50-4A3B-BDCB-20D1009422AB

P921

Q42437041-1568E46B-0D9B-47E4-B78A-DFECC7783710

Q42437041-329371F5-F6D5-4B7F-8620-6F0541A95838

P356

P1433

International Journal of Cancer

P1476

Usage of the NF-kappaB inhibit ...... otherapy of pancreatic cancer.

@en

P2093

André Gehrz

http://www.w3.org/2001/XMLSchema#string

Christina March

http://www.w3.org/2001/XMLSchema#string

Frauke Grohmann

http://www.w3.org/2001/XMLSchema#string

Heiner Schäfer

http://www.w3.org/2001/XMLSchema#string

Holger Kalthoff

http://www.w3.org/2001/XMLSchema#string

Kai Wegehenkel

http://www.w3.org/2001/XMLSchema#string

Maike Witt

http://www.w3.org/2001/XMLSchema#string

Sieglinde Haye

http://www.w3.org/2001/XMLSchema#string

Susanne Müerköster

http://www.w3.org/2001/XMLSchema#string

Ulrich R Fölsch

http://www.w3.org/2001/XMLSchema#string

P2860

Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.

Control of apoptosis by Rel/NF-kappaB transcription factors.

NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases.

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

P304

469-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.10963

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10901666

http://www.w3.org/2001/XMLSchema#string

P698

12584745

http://www.w3.org/2001/XMLSchema#string

P921